A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2011
10/26/2011	EP2379111A1 Narcotic drug formulations with decreased abuse potential
10/26/2011	EP2379110A1 Formulation for the buccal transmucosal administration of setrons
10/26/2011	EP2379079A1 Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
10/26/2011	EP2379064A2 Long circulating nanoparticles for sustained release of therapeutic agents
10/26/2011	EP2379060A2 Extended-release pharmaceutical formulations
10/26/2011	EP2379059A1 Controlled releasing composition
10/26/2011	EP2379054A1 Formulation for delivering lipid-lowering drugs by oral transmucosal administration
10/26/2011	EP2378876A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis
10/26/2011	EP2378873A1 Method of treating neuropathic pain
10/26/2011	EP2378868A2 Aqueous dispersion comprising pesticide particles and an amphiphile
10/26/2011	EP2180027B1 Novel lipid-tripeptide based hydrogel-forming agent and hydrogel
10/26/2011	EP2142169B1 Aqueous pharmaceutical preparation
10/26/2011	EP1848462B1 Methods for treating cancer using an immunotoxin comprising an exotoxin a moiety having a furin cleavage site replaced with a cancer-associated protease site cleaved by mmp-2 or mmp-9
10/26/2011	EP1684719B1 Alpha 1-antitrypsin compositions and treatment methods using such compositions
10/26/2011	EP1602360B1 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof
10/26/2011	EP1575509B1 Epha2 agonistic monoclonal antibodies and methods of use thereof
10/26/2011	EP1427837B1 Modular transfection systems based on nucleoprotein filaments
10/26/2011	CN1901922B Compositions and uses thereof
10/26/2011	CN1662243B Pharmaceutical composition
10/26/2011	CN102227442A Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
10/26/2011	CN102227222A Antitumor agent, method for production of said agent and method for stabilisation thereof
10/26/2011	CN102227214A Compositions with reduced dimer formation
10/26/2011	CN102227213A Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
10/26/2011	CN102227211A Pharmaceutical formulation comprising diclofenac and hydroxy fatty acid polyoxyalkylene ester
10/26/2011	CN102227210A Solution of lipophilic substances, especially medicinal solutions
10/26/2011	CN102226003A Single-arm hyperbranched star-shaped amphiphilic poly(lactic acid)-poly(2-methacryloxyethyl phosphorylcholine) block polymer and preparation method thereof
10/26/2011	CN102225996A Preparation method for benzoxazine resin nano-polymer sphere and benzoxazine resin nano-polymer carbon sphere
10/26/2011	CN102225977A Method for self-stabilized precipitation polymerization in situ preparation of poly(4-ethenyl pyridine)polymer
10/26/2011	CN102225208A Limonene inclusion complex and preparation method thereof
10/26/2011	CN102225207A Dehydrocholic acid-molybdenum heteropoly salt-dehydrocholic acid compound and synthesis method thereof
10/26/2011	CN102225206A Composite for enhancing transdermal administration and application thereof
10/26/2011	CN102225205A Tripterine nano structure lipid carrier and preparation method and application thereof
10/26/2011	CN102225204A Anti-tumour pH sensitive slow release implant and preparation method thereof
10/26/2011	CN102225132A Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof
10/26/2011	CN102225104A Traditional Chinese and western medicine formula for treating hemorrhoid
10/26/2011	CN102225096A Rumex acetosa linn cataplasm and preparation method thereof
10/26/2011	CN102225093A Preparation of Magnolia flower volatile oil soft capsule for treating allergic rhinitis and associated diseases
10/26/2011	CN102225090A Preparation technology for sophora flavescens effervescent tablet
10/26/2011	CN102225072A Sodium humate skin external preparation for promoting wound healing
10/26/2011	CN102225070A Calcium carbonate effervescent granule
10/26/2011	CN102225058A Oseltamivir phosphate dry powder inhalations and preparation method thereof
10/26/2011	CN102225054A Preparation carried with particles of antitumor drug and preparation method thereof
10/26/2011	CN102225053A Vincristine nano targeting slow-release long-circulation liposome and preparation method thereof
10/26/2011	CN102225052A pH-sensitive doxorubicin nano-liposome and preparation method thereof
10/26/2011	CN102225051A pH sensitive doxorubicin nanoliposome modified by folic acid-carboxymethyl chitosan
10/26/2011	CN102225050A Method for preparing famotidine sodium chloride injection by inclusion method and product prepared by using the same
10/26/2011	CN102225047A Enteric solid oral dosage form of bisphosphonate containing a chelating agent
10/26/2011	CN102225046A Transdermal drug delivery formulation
10/26/2011	CN101984960B Rizatriptan benzoate capsule and preparation method thereof
10/26/2011	CN101874777B Spray containing butenafine hydrochloride
10/26/2011	CN101845451B PEI (Polyetherimide)-chitosan triply compound gene vector with low molecular weight and preparation method and application thereof
10/26/2011	CN101780218B Medicinal lotion for treating haemorrhoids
10/26/2011	CN101618029B Soft capsule with function of improving memory and preparation technology thereof
10/26/2011	CN101584764B Medicinal dripping pill for treating chronic cystitis
10/26/2011	CN101450214B Transferrin-frog-egg ribonuclease coupler and production method and use thereof
10/26/2011	CN101406704B Novel plant capsule film material and method for producing the same
10/26/2011	CN101108895B Polyglycol ethanal derivant and combo of medicament and the same
10/26/2011	CN101084980B Medicinal composition freezing-dried powder injection for cancer auxiliary treatment and its preparation method
10/26/2011	CN101007840B Method for keeping activity of active protein under normal temperature
10/25/2011	US8044234 Bioabsorbable surgical composition
10/25/2011	US8044175 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/25/2011	US8044102 administering to animals antibiotic deriavtives such as florfenicol or flunixin meglumine, for prevention of urogenital, respiratory system and gastrointestinal disorders, vision defects and mastitis; veterinary medicine
10/25/2011	US8044099 conjugates of a drug moiety and a pharmacokinetic modulating moiety, they exhibit at least one modulated pharmacokinetic property such as half-life, hepatic first-pass metabolism, volume of distribution and degree of blood protein binding, upon administering to a host
10/25/2011	US8044037 Modified phosphocalcic compound, injectable composition containing same
10/25/2011	US8044035 Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/25/2011	US8044020 Pharmaceutical compositions and methods for insulin treatment
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	US8043630 Shell-and-core dosage form approaching zero-order drug release
10/25/2011	US8043629 Bioabsorbable synthetic nonwoven fabric holding thrombin
10/25/2011	US8043628 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
10/25/2011	US8043610 Freeze-dried composition of inactivated virus envelope with membrane fusion activity
10/25/2011	CA2712304C Recombinant chimeric proteins and methods of use thereof
10/25/2011	CA2598430C Dendritic polymers with enhanced amplification and interior functionality
10/25/2011	CA2580910C Pharmaceutical composition comprising temozolomide ester
10/25/2011	CA2484020C Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/25/2011	CA2454658C Methods for treating joint inflammation, pain, and loss of mobility
10/25/2011	CA2437983C Transporters comprising spaced arginine moieties
10/25/2011	CA2341568C Stabilized pharmaceutical composition in lyophilized form
10/23/2011	CA2737978A1 Biodegradable polymer system
10/20/2011	WO2011130753A2 Functionalized nano- and micro-materials for medical therapies
10/20/2011	WO2011130613A1 Targeted pyrrolobenzodiazapine conjugates
10/20/2011	WO2011130598A1 Pyrrolobenzodiazepines and conjugates thereof
10/20/2011	WO2011130500A1 Formulations of a pyridazine bipyrazinyl
10/20/2011	WO2011130462A2 Intraocular pressure reduction with intracameral bimatoprost implants
10/20/2011	WO2011130440A1 Effervescent tablets comprising an oil component
10/20/2011	WO2011130246A2 Compositions with reactive ingredients, and wound dressings, apparatuses, and methods
10/20/2011	WO2011129812A1 Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same
10/20/2011	WO2011129627A2 Docetaxel-loaded thermosensitive liquid suppository composition for rectal administration
10/20/2011	WO2011129461A1 Method and ophthalmic composition for treating retinal disease
10/20/2011	WO2011129269A1 Adhesive composition for medical use, adhesive patch for medical use, and method for producing the composition
10/20/2011	WO2011129120A1 Methods and compositions for intranasal delivery
10/20/2011	WO2011128910A2 A drug delivery solid dosage formulation of sirolimus
10/20/2011	WO2011128896A1 Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders
10/20/2011	WO2011128642A1 Compoisitons comprising polyglutamic acid nanoparticles and polypeptides such as cd40 agonists
10/20/2011	WO2011128634A2 Over the counter pharmaceutical compositions
10/20/2011	WO2011128632A2 Gelled pharmaceutical composition
10/20/2011	WO2011128631A2 Vegetarian oral pharmaceutical and nutraceutical compositions
10/20/2011	WO2011128630A2 Anti-abuse gelled pharmaceutical compositions
10/20/2011	WO2011128629A2 Lipid-vectored drug compositions
10/20/2011	WO2011128597A1 Novel formulations of active ingredient(s) of plant origin or synthetic analogues thereof or of extract(s) of plant origin containing same, and of lecithin

1 ... 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 ... 1712